-
Zydus Receives USFDA Orphan Drug Designation for Desidustat in Beta-Thalassemia Treatment
November 6, 2025In a significant step toward advancing treatments for rare blood disorders, Zydus Lifesciences Limited has announced...
-
Xiom Healthcare Launches ‘Health Imagined’— A Free Digital OPD Platform to Transform Patient Care
September 15, 2025Xiom Healthcare has announced the launch of Health Imagined (Hi), a free digital OPD platform designed...
-
Russian mRNA Cancer Vaccine Enteromix Sparks Hope — But Experts Urge Caution
September 9, 2025Enteromix represents hope tempered with caution. The vaccine is a reminder that while science continues to...
-
70% of Knee and Shoulder Injuries Caused by Falls — Apollo Hospitals
August 29, 2025Knee and shoulder injuries remain among the most common orthopaedic challenges today, with nearly 70% of cases linked to everyday...
-
Ozempic Faces $2 Billion in Lawsuits as Patients Report Stomach Paralysis and Vision Loss
August 26, 2025Ozempic, along with sister drugs Wegovy and Rybelsus, belongs to the GLP-1 receptor agonist class of...
-
Johnson & Johnson Launches The 3rd Opinion to Empower Lung Cancer Patients Across Asia Pacific
August 1, 2025Marking World Lung Cancer Day, Johnson & Johnson has unveiled The 3rd Opinion, a groundbreaking initiative...
-
Zydus Receives Tentative USFDA Approval for Ibrutinib Tablets in Multiple Strengths, Targeting $2.1 Billion Market
July 24, 2025Zydus Lifesciences Ltd., one of India’s leading pharmaceutical companies, announced today that it has received tentative...
